RLAY · Categories · Form 4

RLAY - SEC Form 4 insider transactions

Relay Therapeutics Inc. (RLAY) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for RLAY

• 26d
  Chief Financial Officer Catinazzo Thomas sold $227,841 worth of shares (17,717 units at $12.86) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 195,178 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 40d
  Chief Financial Officer Catinazzo Thomas sold $14,376 worth of shares (972 units at $14.79), decreasing direct ownership by 0.45% to 212,895 units (SEC Form 4) to satisfy tax liability

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 40d
  Officer Rahmer Peter sold $11,137 worth of shares (753 units at $14.79), decreasing direct ownership by 0.27% to 275,857 units (SEC Form 4) (tax withholding)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 40d
  President, R&D Bergstrom Donald A sold $22,037 worth of shares (1,490 units at $14.79), decreasing direct ownership by 0.35% to 418,557 units (SEC Form 4) to satisfy withholding tax

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 61d
  SEC Form 4 filed by Catinazzo Thomas

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 90d
  SEC Form 4 filed by Relay Therapeutics Inc.

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 131d
  President, R&D Bergstrom Donald A sold $166,677 worth of shares (21,581 units at $7.72), decreasing direct ownership by 5% to 420,047 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 131d
  Officer Rahmer Peter was granted 994 shares and sold $100,473 worth of shares (13,038 units at $7.71), decreasing direct ownership by 18% to 276,610 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 131d
  Chief Financial Officer Catinazzo Thomas sold $119,631 worth of shares (15,515 units at $7.71), decreasing direct ownership by 6% to 249,301 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 145d
  SEC Form 4 filed by President, R&D Bergstrom Donald A

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 145d
  SEC Form 4 filed by Officer Rahmer Peter

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 145d
  SEC Form 4 filed by President and CEO Patel Sanjiv

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 145d
  SEC Form 4 filed by Chief Financial Officer Catinazzo Thomas

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 153d
  President and CEO Patel Sanjiv was granted 994 shares and sold $337,574 worth of shares (43,168 units at $7.82), decreasing direct ownership by 6% to 661,041 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 215d
  SEC Form 4 filed by Director Coats Lonnel

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 215d
  SEC Form 4 filed by Director Dable Habib J

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 217d
  President and CEO Patel Sanjiv sold $434,511 worth of shares (62,073 units at $7.00), decreasing direct ownership by 8% to 703,215 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 222d
  Officer Rahmer Peter sold $299,949 worth of shares (40,529 units at $7.40), decreasing direct ownership by 11% to 337,469 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 222d
  Chief Financial Officer Catinazzo Thomas sold $157,931 worth of shares (21,664 units at $7.29), decreasing direct ownership by 6% to 313,631 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 222d
  President, R&D Bergstrom Donald A sold $225,239 worth of shares (30,897 units at $7.29), decreasing direct ownership by 6% to 521,823 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 314d
  Chief Financial Officer Catinazzo Thomas sold $74,000 worth of shares (20,081 units at $3.69), decreasing direct ownership by 6% to 335,295 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 314d
  Officer Rahmer Peter sold $62,947 worth of shares (17,083 units at $3.68), decreasing direct ownership by 4% to 377,998 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 314d
  President, R&D Bergstrom Donald A sold $113,478 worth of shares (30,770 units at $3.69), decreasing direct ownership by 5% to 552,720 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 314d
  Chief Legal Officer Adams Brian sold $73,378 worth of shares (19,913 units at $3.68), decreasing direct ownership by 5% to 371,472 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 334d
  President and CEO Patel Sanjiv sold $219,123 worth of shares (61,379 units at $3.57), decreasing direct ownership by 7% to 765,288 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 343d
  Officer Rahmer Peter was granted 5,000 shares, increasing direct ownership by 1% to 395,081 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 343d
  President and CEO Patel Sanjiv was granted 5,000 shares, increasing direct ownership by 0.61% to 826,667 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 363d
  SEC Form 4 filed by Director Mazumdar Claire

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 368d
  SEC Form 4 filed by Director Hill Linda A

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 368d
  SEC Form 4 filed by Director Borisy Alexis

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 368d
  SEC Form 4 filed by Director Ingram Douglas S

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 368d
  SEC Form 4 filed by Director Kathiresan Sekar

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 368d
  SEC Form 4 filed by Director Murcko Mark

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 368d
  SEC Form 4 filed by Director Rubin Jami

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 405d
  Officer Rahmer Peter sold $36,541 worth of shares (12,103 units at $3.02), decreasing direct ownership by 3% to 390,081 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 405d
  Chief Financial Officer Catinazzo Thomas sold $58,849 worth of shares (19,191 units at $3.07), decreasing direct ownership by 5% to 355,376 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 405d
  President, R&D Bergstrom Donald A sold $95,381 worth of shares (31,562 units at $3.02), decreasing direct ownership by 5% to 583,490 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 405d
  Chief Legal Officer Adams Brian sold $44,040 worth of shares (14,587 units at $3.02), decreasing direct ownership by 4% to 391,385 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 411d
  President and CEO Patel Sanjiv sold $182,423 worth of shares (61,422 units at $2.97), decreasing direct ownership by 7% to 821,667 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 435d
  President, R&D Bergstrom Donald A sold $2,800 worth of shares (986 units at $2.84), decreasing direct ownership by 0.16% to 615,052 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 435d
  Officer Rahmer Peter sold $701 worth of shares (247 units at $2.84), decreasing direct ownership by 0.06% to 402,184 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 435d
  Chief Financial Officer Catinazzo Thomas sold $13,814 worth of shares (4,864 units at $2.84), decreasing direct ownership by 1% to 374,567 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 435d
  Chief Legal Officer Adams Brian sold $846 worth of shares (298 units at $2.84), decreasing direct ownership by 0.07% to 405,972 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 480d
  President and CEO Patel Sanjiv sold $818,400 worth of shares (215,506 units at $3.80) and was granted 332,465 shares, increasing direct ownership by 15% to 883,089 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 494d
  Officer Rahmer Peter sold $204,753 worth of shares (45,464 units at $4.50) and was granted 139,141 shares, increasing direct ownership by 30% to 402,431 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 494d
  Chief Financial Officer Catinazzo Thomas sold $268,339 worth of shares (58,936 units at $4.55) and was granted 139,141 shares, increasing direct ownership by 27% to 379,431 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 494d
  President, R&D Bergstrom Donald A sold $362,298 worth of shares (80,450 units at $4.50) and was granted 176,400 shares, increasing direct ownership by 18% to 616,038 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 494d
  Chief Legal Officer Adams Brian sold $247,872 worth of shares (54,479 units at $4.55) and was granted 139,141 shares, increasing direct ownership by 26% to 406,270 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 502d
  President and CEO Patel Sanjiv sold $1,762,500 worth of shares (375,000 units at $4.70) (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 510d
  SEC Form 4 filed by Officer Rahmer Peter

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 510d
  SEC Form 4 filed by President, R&D Bergstrom Donald A

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 510d
  SEC Form 4 filed by President and CEO Patel Sanjiv

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 510d
  SEC Form 4 filed by Chief Financial Officer Catinazzo Thomas

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 510d
  SEC Form 4 filed by Chief Legal Officer Adams Brian

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 519d
  Officer Rahmer Peter sold $345,572 worth of shares (80,909 units at $4.27), decreasing direct ownership by 21% to 308,754 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 525d
  Officer Rahmer Peter sold $1,752 worth of shares (400 units at $4.38), decreasing direct ownership by 0.10% to 389,663 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 525d
  President, R&D Bergstrom Donald A sold $2,878 worth of shares (657 units at $4.38), decreasing direct ownership by 0.13% to 520,088 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 525d
  Chief Legal Officer Adams Brian sold $1,310 worth of shares (299 units at $4.38), decreasing direct ownership by 0.09% to 321,608 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 525d
  Chief Financial Officer Catinazzo Thomas sold $21,491 worth of shares (4,865 units at $4.42), decreasing direct ownership by 2% to 299,226 units (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)
• 538d
  President and CEO Patel Sanjiv sold $500,000 worth of shares (100,000 units at $5.00) (SEC Form 4)

  4 - Relay Therapeutics, Inc. (0001812364) (Issuer)

Other RLAY categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends